{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:58:58Z","timestamp":1791129538692,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinre.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T13:40:01Z","timestamp":1317476401000},"page":"805-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Liver transplantation and hepatitis\u00a0C"],"prefix":"10.1016","volume":"35","author":[{"given":"A.","family":"Rub\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.04.009_bib0005","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/jhep.2002.31773","article-title":"Hepatitis\u00a0C virus kinetics during and immediately after liver transplantation","volume":"35","author":"Garc\u00eda-Retortillo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0168-8278(01)00179-9","article-title":"Hepatitis\u00a0C and liver transplantation","volume":"35","author":"Berenguer","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.04.009_bib0015","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1053\/jlts.2003.50248","article-title":"The natural history and outcome of liver transplantation in hepatitis\u00a0C virus-infected recipients","volume":"9","author":"Gane","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2011.04.009_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/jlts.2003.50240","article-title":"Delayed onset of severe hepatitis\u00a0C-related liver damage following liver transplantation: a matter of concern?","volume":"9","author":"Berenguer","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":"Fibrosis progression after liver transplantation in patients with recurrent hepatitis\u00a0C","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2202\/1557-4679.1213","article-title":"Non-Markov multistate modelling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis\u00a0C following liver transplantation","volume":"6","author":"Bacchetti","year":"2010","journal-title":"Int J Biostatistics"},{"issue":"11","key":"10.1016\/j.clinre.2011.04.009_bib0040","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/lt.22175","article-title":"Post-liver transplant cholestatic hepatitis\u00a0C: a systematic review of clinical and pathological findings and application of consensus criteria","volume":"16","author":"Narang","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0045","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/jhep.2000.17924","article-title":"Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation","volume":"32","author":"Berenguer","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis\u00a0C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-6143.2007.02082.x","article-title":"Improving outcomes of liver retransplantation: an analysis of trends and the impact of hepatitis\u00a0C infection","volume":"8","author":"Ghabril","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/gut.50.5.697","article-title":"Histology predicts cirrhotic evolution of post transplant hepatitis\u00a0C","volume":"50","author":"Guido","year":"2002","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.clinre.2011.04.009_bib0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181bd783c","article-title":"Antiviral treatment of recurrent hepatitis\u00a0C after liver transplantation: predictors of response and long-term outcome","volume":"88","author":"Selzner","year":"2009","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.clinre.2011.04.009_bib0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/lt.21707","article-title":"Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis\u00a0C: impact of donor age and baseline cirrhosis","volume":"15","author":"Berenguer","year":"2009","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.clinre.2011.04.009_bib0075","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/lt.21635","article-title":"Hepatitis\u00a0C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis","volume":"14","author":"Roche","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.clinre.2011.04.009_bib0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.21090","article-title":"Hepatic venous pressure gradient identifies patients at risk of severe hepatitis\u00a0C recurrence after liver transplantation","volume":"43","author":"Blasco","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hep.23240","article-title":"Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis\u00a0C virus recurrence after liver transplantation","volume":"51","author":"Carri\u00f3n","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jhep.2006.05.001","article-title":"Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January\u00a012\u201314, 2006)","volume":"45","author":"Samuel","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.04.009_bib0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first international liver transplant society consensus conference on liver transplantation and hepatitis\u00a0C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.clinre.2011.04.009_bib0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","article-title":"What determines the natural history of recurrent hepatitis\u00a0C after liver transplantation","volume":"42","author":"Berenguer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.04.009_bib0105","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/jlts.2003.50264","article-title":"The role of immunosuppression in recurrence of hepatitis\u00a0C","volume":"9","author":"Lake","year":"2003","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.clinre.2011.04.009_bib0110","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1600-6143.2006.01408.x","article-title":"The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis\u00a0C","volume":"6","author":"Foxton","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis\u00a0C after liver transplantation in patients co-infected with human immunodeciency virus and hepatitis\u00a0C virus","volume":"47","author":"Duclos-Vallee","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2011.04.009_bib0125","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/lt.21747","article-title":"Early high peak hepatitis\u00a0C viral load levels independently predict hepatitis\u00a0C-related liver failure post-liver transplantation","volume":"15","author":"Shackel","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis\u00a0C recurrence after liver transplantation: a randomized controlled study","volume":"132","author":"Carrion","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis\u00a0C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/lt.21652","article-title":"Long-term antiviral therapy for recurrent hepatitis\u00a0C after liver transplantation in non responders: biochemical, virological, and histological impact","volume":"15","author":"Walter","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.20560","article-title":"Peginterferon alfa-2a for hepatitis\u00a0C after liver transplantation: two randomized, controlled trials","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-6143.2004.00648.x","article-title":"Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis\u00a0C-infected patients undergoing liver transplantation","volume":"5","author":"Shergill","year":"2005","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.clinre.2011.04.009_bib0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis\u00a0C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.04.009_bib0160","doi-asserted-by":"crossref","unstructured":"Selzner N, Guindi M, Renner EL, Berenguer M. Immune-mediated complications of the graft in interferon-treated hepatitis\u00a0C positive liver transplant recipients. J Hepatol 2010 [Epub ahead of print].","DOI":"10.1016\/j.jhep.2010.11.012"},{"key":"10.1016\/j.clinre.2011.04.009_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis\u00a0C recurrence: possible de novo autoimmune hepatitis?","volume":"56","author":"Berardi","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.04.009_bib0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1600-6143.2006.01362.x","article-title":"Interferon-based combination therapy for hepatitis\u00a0C virus after liver transplantation: a review and quantitative analysis","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinre.2011.04.009_bib0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2893.2008.01019.x","article-title":"Pegylated interferon and ribavirn in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective studies","volume":"15","author":"Xirouchakis","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2011.04.009_bib0180","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/lt.21760","article-title":"Predictors of sustained virological response after antiviral treatment for hepatitis\u00a0C recurrence following liver transplantation","volume":"15","author":"Cescon","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.04.009_bib0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10620-009-0981-3","article-title":"The use of cyclosporine for recurrent hepatitis\u00a0C after liver transplant: a randomized pilot study","volume":"55","author":"Firpi","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.04.009_bib0190","doi-asserted-by":"crossref","unstructured":"Lange CM, Moradpour D, Doehring A, et al. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis\u00a0C virus liver graft reinfection. J Hepatol 2010 Dec 13. [Epub ahead of print]; PubMed PMID: 21147186.","DOI":"10.1016\/j.jhep.2010.10.037"},{"issue":"5","key":"10.1016\/j.clinre.2011.04.009_bib0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1053\/j.gastro.2010.07.058","article-title":"Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis\u00a0C","volume":"139","author":"Fukuhara","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2011.04.009_bib40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1600-6143.2011.03491.x","article-title":"Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation","volume":"11","author":"Coto-Llerena","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.24074","article-title":"Interleukin 28-B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis\u00a0C virus infection","volume":"53","author":"Charlton","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.04.009_bib0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2893.2006.00714.x","article-title":"Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis\u00a0C virus infection","volume":"13","author":"Feliu","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.clinre.2011.04.009_bib0215","unstructured":"Lopez-Labrador FX, Berenguer M. Genomic medicine reaches HCV-related liver transplantation: hopes and clinical and Public Health implications. J Hepatol 2011 (in press)."},{"issue":"12","key":"10.1016\/j.clinre.2011.04.009_bib0220","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/lt.20857","article-title":"Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis\u00a0C recurrence after liver transplantation","volume":"12","author":"Carri\u00f3n","year":"2006","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.clinre.2011.04.009_bib0225","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gut.2007.135046","article-title":"Transient elastography predicts fibrosis progression in patients with recurrent hepatitis\u00a0C after liver transplantation","volume":"57","author":"Rigamonti","year":"2008","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.tp.0000297248.18483.16","article-title":"Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis\u00a0C after living donor liver transplantation","volume":"85","author":"Harada","year":"2008","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.clinre.2011.04.009_bib0235","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/lt.21919","article-title":"Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis\u00a0C virus-infected liver transplant recipients","volume":"15","author":"Benlloch","year":"2009","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.gastro.2009.09.047","article-title":"Serum fibrosis markers identify patients with mild and progressive hepatitis\u00a0C recurrence after liver transplantation","volume":"138","author":"Carri\u00f3n","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clinre.2011.04.009_bib0245","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/lt.21828","article-title":"Recipient age affects long-term outcome and hepatitis\u00a0C recurrence in old donor livers following transplantation","volume":"15","author":"Selzner","year":"2009","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.clinre.2011.04.009_bib0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.20995","article-title":"Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation","volume":"13","author":"Terrault","year":"2007","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.clinre.2011.04.009_bib0255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/lt.21524","article-title":"The significance of metabolic syndrome in the setting of recurrent hepatitis\u00a0C after liver transplantation","volume":"14","author":"Hanouneh","year":"2008","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.clinre.2011.04.009_bib0260","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.01.005","article-title":"Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression","volume":"44","author":"Berenguer","year":"2006","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2011.04.009_bib0265","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/TP.0b013e3181fa93fa","article-title":"Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis\u00a0C virus-positive recipients","volume":"90","author":"Berenguer","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.04.009_bib0270","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/lt.21182","article-title":"Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study","volume":"13","author":"Klintmalm","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.clinre.2011.04.009_bib0275","doi-asserted-by":"crossref","unstructured":"McKenna GJ, Trotter JF, Klintmlam E et al. Limiting hepatitis C virus progression in liver transplant recipients using sirolimus based immunosuppression. Am J Transpl 2011. (in press).","DOI":"10.1111\/j.1600-6143.2011.03767.x"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074011100146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074011100146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:50Z","timestamp":1761894770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074011100146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S221074011100146X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.04.009","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplantation and hepatitis\u00a0C","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}